A Phase 2, Double-blind, Randomized, Placebo-controlled Pharmacokinetic Trial in 2 Parallel Groups to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and GWP42003-P in Patients With Epilepsy
Phase of Trial: Phase II
Latest Information Update: 20 Mar 2017
At a glance
- Drugs Cannabidiol (Primary) ; Stiripentol; Valproate
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors GW Pharmaceuticals
- 25 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Mar 2017.
- 25 Oct 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Mar 2017.
- 25 Oct 2016 Status changed from not yet recruiting to recruiting.